Barry M Salzman insider trades
Open-market stock purchases and sales by Barry M Salzman, Director at Checkpoint Therapeutics, Inc, from SEC Form 4 filings since Jun 15, 2017.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- CKPT Checkpoint Therapeutics, Inc: other filings, last May 30, 2025